Showing results (441-450 of 492) with videos related to

Sort By:
Pageof 50
American Journal of Respiratory Cell and Molecular Biology|August 6, 2016
Hypoxia-Inducible Factor-1α Regulates CD55 in Airway EpitheliumPankita H Pandya, Amanda J Fisher, Elizabeth A Mickler, et al.
Bioorganic & Medicinal Chemistry Letters|October 26, 2016
Mesoionic pyrido[1,2-a]pyrimidinones: A novel class of insecticides inhibiting nicotinic acetylcholine receptorsWenming Zhang, Caleb W Holyoke, James Barry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2002
Vitamin E succinate is a potent novel antineoplastic agent with high selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) in vivoTobias Weber, Min Lu, Ladislav Andera, et al.
Bioorganic & Medicinal Chemistry Letters|September 22, 2007
Rynaxypyr: a new insecticidal anthranilic diamide that acts as a potent and selective ryanodine receptor activatorGeorge P Lahm, Thomas M Stevenson, Thomas P Selby, et al.
American Journal of Respiratory and Critical Care Medicine|March 3, 2012
17β-Estradiol attenuates hypoxic pulmonary hypertension via estrogen receptor-mediated effectsTim Lahm, Marjorie Albrecht, Amanda J Fisher, et al.
Scientific Reports|July 12, 2019
Myosin binding protein H-like (MYBPHL): a promising biomarker to predict atrial damageHarald Lahm, Martina Dreßen, Nicole Beck, et al.
International Journal of Molecular Sciences|February 14, 2020
miR-128a Acts as a Regulator in Cardiac Development by Modulating Differentiation of Cardiac Progenitor Cell PopulationsSarah C Hoelscher, Theresia Stich, Anne Diehm, et al.
Bioorganic & Medicinal Chemistry Letters|January 15, 2017
Mesoionic pyrido[1,2-a]pyrimidinones: Discovery of dicloromezotiaz as a lepidoptera insecticide acting on nicotinic acetylcholine receptors<sup>1,2</sup>Wenming Zhang, Caleb W Holyoke, James Barry, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|November 14, 2013
Development of a neuromedin U-human serum albumin conjugate as a long-acting candidate for the treatment of obesity and diabetes. Comparison with the PEGylated peptidePhilippe Neuner, Andrea M Peier, Fabio Talamo, et al.
Nature Communications|January 28, 2018
Distinct epigenetic programs regulate cardiac myocyte development and disease in the human heart in vivoRalf Gilsbach, Martin Schwaderer, Sebastian Preissl, et al.
Pageof 50